搜尋





搜尋





市場行情
/
股票
/
crsp
/

CRISPR Therapeutics AG

CRSP

添加自選

47.640USD

+0.090+0.19%

收盤 07-29 16:00（美東）報價延遲15分鐘

4.59B總市值

虧損本益比TTM

CRISPR Therapeutics AG

47.640

+0.090+0.19%

概覽

財務

分析

公司

財務摘要利潤表資產負債表現金流量表

CRSP 利潤表

您可以在這裡找到CRISPR Therapeutics AG的年度或季度收入報告，以深入了解CRISPR Therapeutics AG的營運、管理效率和表現。

單季報

單季報+年報

單季報

年報

YOY

隱藏空白列

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

FY2020Q2

FY2020Q1

FY2019Q4

FY2019Q3

FY2019Q2

FY2019Q1

FY2018Q4

FY2018Q3

FY2018Q2

FY2018Q1

FY2017Q4

FY2017Q3

FY2017Q2

FY2017Q1

FY2016Q4

FY2016Q3

FY2016Q2

FY2016Q1

FY2015Q4

FY2015Q3

FY2015Q2

FY2015Q1

營業總收入

68.55%1.46M

-97.58%864.00K

47.67%889.00K

72.53%892.00K

71.63%865.00K

-82.26%35.69M

--602.00K

-99.26%517.00K

-99.50%504.00K

3353333.33%201.21M

-100.00%0.00

44203.80%70.00M

10538.30%100.00M

-99.95%6.00K

-88.59%94.00K

-99.98%158.00K

74.40%940.00K

3386.22%12.90M

456.76%824.00K

2046947.73%900.70M

243.31%539.00K

-99.52%370.00K

-99.93%148.00K

-86.16%44.00K

-52.13%157.00K

66870.43%77.02M

37542.63%211.93M

-70.77%318.00K

-75.85%328.00K

-99.64%115.00K

-76.41%563.00K

-69.63%1.09M

-49.76%1.36M

1279.05%32.33M

54.10%2.39M

350.57%3.58M

467.86%2.70M

848.99%2.34M

--1.55M

--795.00K

--476.00K

--247.00K

--0.00

營業收入

68.55%1.46M

-97.58%864.00K

47.67%889.00K

72.53%892.00K

71.63%865.00K

-82.26%35.69M

--602.00K

-99.26%517.00K

-99.50%504.00K

3353333.33%201.21M

-100.00%0.00

44203.80%70.00M

10538.30%100.00M

-99.95%6.00K

-88.59%94.00K

-99.98%158.00K

74.40%940.00K

3386.22%12.90M

456.76%824.00K

2046947.73%900.70M

243.31%539.00K

-99.52%370.00K

-99.93%148.00K

-86.16%44.00K

-52.13%157.00K

66870.43%77.02M

37542.63%211.93M

-70.77%318.00K

-75.85%328.00K

-99.64%115.00K

-76.41%563.00K

-69.63%1.09M

-49.76%1.36M

1279.05%32.33M

54.10%2.39M

350.57%3.58M

467.86%2.70M

848.99%2.34M

--1.55M

--795.00K

--476.00K

--247.00K

--0.00

營業費用

-11.78%131.71M

55.20%155.63M

20.06%132.95M

-11.74%133.96M

5.81%149.29M

-23.81%100.28M

-16.37%110.73M

-8.14%151.78M

-14.22%141.09M

0.06%131.62M

-27.44%132.41M

-9.92%165.22M

-7.02%164.49M

-17.06%131.55M

40.72%182.48M

32.83%183.42M

53.73%176.91M

46.67%158.60M

40.12%129.67M

71.04%138.08M

56.06%115.08M

63.75%108.13M

27.19%92.55M

45.99%80.73M

51.26%73.74M

45.63%66.03M

45.54%72.77M

44.11%55.30M

71.93%48.75M

44.62%45.34M

92.61%49.99M

54.19%38.37M

20.93%28.36M

13.38%31.35M

60.63%25.96M

43.42%24.89M

93.33%23.45M

122.78%27.65M

160.54%16.16M

378.70%17.35M

224.63%12.13M

--12.41M

--6.20M

--3.63M

--3.74M

研發費用

-5.39%68.57M

1.67%83.53M

-28.31%58.90M

-12.81%69.89M

-4.84%72.48M

-13.65%82.16M

-9.41%82.16M

-21.06%80.17M

-23.78%76.17M

-8.12%95.14M

-22.23%90.70M

-17.58%101.56M

-15.48%99.94M

-22.99%103.56M

10.73%116.62M

13.80%123.22M

30.56%118.25M

63.26%134.47M

48.32%105.32M

82.35%108.28M

67.12%90.56M

68.92%82.36M

24.04%71.01M

50.20%59.38M

60.23%54.19M

69.30%48.76M

43.76%57.25M

54.23%39.53M

73.28%33.82M

43.79%28.80M

123.14%39.82M

49.73%25.63M

31.84%19.52M

28.63%20.03M

48.07%17.84M

99.02%17.12M

146.26%14.80M

152.22%15.57M

221.47%12.05M

478.87%8.60M

416.49%6.01M

--6.17M

--3.75M

--1.49M

--1.16M

折舊攤銷及損耗

-8.80%4.32M

16.91%5.66M

-7.65%4.43M

-4.05%4.65M

-2.01%4.74M

-1.18%4.84M

-2.54%4.80M

-3.10%4.84M

-4.32%4.83M

-16.18%4.90M

-1.85%4.92M

-31.21%5.00M

-16.36%5.05M

-6.63%5.85M

-5.75%5.02M

98.99%7.27M

122.43%6.04M

144.00%6.26M

128.01%5.32M

66.05%3.65M

29.29%2.71M

79.19%2.57M

79.62%2.33M

83.64%2.20M

110.00%2.10M

39.57%1.43M

47.23%1.30M

33.11%1.20M

21.07%1.00M

4.48%1.03M

10.38%883.00K

27.48%900.00K

14.72%826.00K

101.64%982.00K

238.98%800.00K

312.87%706.00K

526.09%720.00K

725.42%487.00K

490.00%236.00K

1121.43%171.00K

721.43%115.00K

--59.00K

--40.00K

--14.00K

營業利潤

12.25%-130.25M

-139.62%-154.76M

-19.91%-132.06M

12.02%-133.07M

-5.57%-148.42M

-192.82%-64.59M

16.83%-110.13M

-58.85%-151.26M

-118.01%-140.59M

152.90%69.58M

27.40%-132.41M

48.04%-95.22M

63.35%-64.49M

9.72%-131.54M

-41.55%-182.39M

-124.03%-183.26M

-53.63%-175.97M

-35.20%-145.70M

-39.45%-128.85M

1045.13%762.62M

-55.66%-114.54M

-1081.16%-107.76M

-166.40%-92.40M

-46.75%-80.69M

-51.96%-73.59M

124.28%10.98M

381.52%139.16M

-47.46%-54.98M

-79.36%-48.42M

-4753.09%-45.23M

-109.72%-49.43M

-75.00%-37.29M

-30.14%-27.00M

103.84%972.00K

-61.33%-23.57M

-28.67%-21.31M

-78.03%-20.74M

-108.04%-25.31M

-135.57%-14.61M

-356.77%-16.56M

-211.88%-11.65M

---12.17M

---6.20M

---3.63M

---3.74M

淨非營業利息收入（費用）

利息費用

----

--0.00

----

--0.00

-100.00%0.00

--0.00

-100.00%0.00

----

-87.50%1.00K

-100.00%0.00

--8.05M

--99.00K

--8.00K

--1.00K

--0.00

股權收益

----

--0.00

100.00%0.00

-238.93%-3.43M

12.23%-1.01M

6.05%-1.02M

-124.94%-1.02M

-181.89%-1.01M

-128.32%-1.15M

-144.62%-1.09M

98.74%-453.00K

---359.00K

26.38%-505.00K

---446.00K

---35.85M

--0.00

---686.00K

----

--0.00

----

特殊收入（費用）

----

--0.00

---96.25M

----

--0.00

----

--0.00

-100.00%0.00

--0.00

--11.48M

--0.00

其他非經營性收入（費用）

-39.75%8.16M

-11.48%24.77M

4.68%26.24M

-15.58%22.07M

-45.24%13.54M

39.91%27.98M

21.25%25.06M

42.01%26.14M

94.00%24.72M

74.04%20.00M

184.57%20.67M

419.36%18.41M

3410.19%12.74M

422.99%11.49M

559.76%7.26M

372.53%3.54M

-81.43%363.00K

282.09%2.20M

588.13%1.10M

-46.88%750.00K

-53.80%1.96M

-97.06%575.00K

-94.60%160.00K

-40.70%1.41M

276.18%4.23M

1864.02%19.56M

2380.00%2.96M

1436.13%2.38M

992.86%1.13M

-2804.88%-1.11M

-83.10%-130.00K

196.27%155.00K

-2000.00%-126.00K

-99.95%41.00K

5.33%-71.00K

-301.25%-161.00K

95.89%-6.00K

160416.33%78.65M

-933.33%-75.00K

175.86%80.00K

-105.63%-146.00K

--49.00K

--9.00K

--29.00K

---71.00K

稅前利潤

9.49%-122.09M

-255.08%-130.00M

-24.40%-105.82M

-65.65%-207.26M

-16.42%-134.89M

-140.87%-36.61M

23.87%-85.07M

-62.88%-125.12M

-123.92%-115.87M

174.62%89.58M

36.19%-111.74M

57.26%-76.82M

70.53%-51.74M

16.34%-120.05M

-37.09%-175.12M

-123.54%-179.72M

-55.97%-175.61M

-33.88%-143.50M

-38.50%-127.75M

1062.91%763.37M

-62.34%-112.59M

-450.90%-107.19M

-166.50%-92.24M

-47.87%-79.28M

-43.52%-69.35M

164.50%30.55M

374.25%138.70M

-40.04%-53.61M

-71.27%-48.32M

-8556.43%-47.36M

-110.73%-50.57M

-74.24%-38.28M

-33.11%-28.21M

-96.80%560.00K

-63.42%-24.00M

-28.01%-21.97M

-153.36%-21.20M

243.24%17.50M

-136.83%-14.69M

-377.18%-17.16M

-119.75%-8.37M

---12.22M

---6.20M

---3.60M

---3.81M

所得稅

-24.35%839.00K

-12.29%614.00K

-29.34%619.00K

0.39%1.29M

53.18%1.11M

200.43%700.00K

112.62%876.00K

39.44%1.29M

-45.15%724.00K

102.46%233.00K

171.65%412.00K

-84.91%923.00K

-63.41%1.32M

-320.59%-9.48M

3.36%-575.00K

47.67%6.12M

527.48%3.61M

-1432.65%-2.25M

-397.50%-595.00K

993.14%4.14M

52.52%575.00K

-3775.00%-147.00K

-27.01%200.00K

345.88%379.00K

343.53%377.00K

-98.29%4.00K

100.00%274.00K

-11.46%85.00K

-1.16%85.00K

-44.15%234.00K

-80.62%137.00K

-72.01%96.00K

-69.18%86.00K

4.75%419.00K

8737.50%707.00K

--343.00K

267.11%279.00K

471.43%400.00K

-94.77%8.00K

-100.00%0.00

126.67%76.00K

--70.00K

--153.00K

--69.00K

---285.00K

除稅後利潤

9.61%-122.93M

-250.07%-130.61M

-23.85%-106.44M

-64.98%-208.55M

-16.64%-136.00M

-141.76%-37.31M

23.37%-85.94M

-62.60%-126.41M

-119.71%-116.59M

180.80%89.35M

35.75%-112.15M

58.17%-77.74M

70.39%-53.06M

21.72%-110.58M

-37.27%-174.55M

-124.48%-185.83M

-58.37%-179.22M

-31.96%-141.25M

-37.55%-127.15M

1053.13%759.23M

-62.29%-113.16M

-450.46%-107.04M

-166.78%-92.44M

-48.34%-79.66M

-44.05%-69.73M

164.18%30.54M

372.96%138.42M

-39.91%-53.70M

-71.05%-48.41M

-33851.77%-47.59M

-105.25%-50.71M

-71.99%-38.38M

-31.78%-28.30M

-99.18%141.00K

-68.14%-24.71M

-30.01%-22.32M

-154.38%-21.48M

239.17%17.10M

-131.26%-14.69M

-368.19%-17.16M

-139.69%-8.44M

---12.29M

---6.35M

---3.67M

---3.52M

持續經營利潤

9.61%-122.93M

-250.07%-130.61M

-23.85%-106.44M

-64.98%-208.55M

-16.64%-136.00M

-141.76%-37.31M

23.37%-85.94M

-62.60%-126.41M

-119.71%-116.59M

180.80%89.35M

35.75%-112.15M

58.17%-77.74M

70.39%-53.06M

21.72%-110.58M

-37.27%-174.55M

-124.48%-185.83M

-58.37%-179.22M

-31.96%-141.25M

-37.55%-127.15M

1053.13%759.23M

-62.29%-113.16M

-450.46%-107.04M

-166.78%-92.44M

-48.34%-79.66M

-44.05%-69.73M

164.18%30.54M

372.96%138.42M

-39.91%-53.70M

-71.05%-48.41M

-33851.77%-47.59M

-105.25%-50.71M

-71.99%-38.38M

-31.78%-28.30M

-99.18%141.00K

-68.14%-24.71M

-30.01%-22.32M

-154.38%-21.48M

239.17%17.10M

-131.26%-14.69M

-368.19%-17.16M

-139.69%-8.44M

---12.29M

---6.35M

---3.67M

---3.52M

歸屬少數股東的淨利潤

----

--0.00

----

100.00%0.00

----

100.00%0.00

93.75%-1.00K

-1300.00%-14.00K

69.57%-7.00K

98.95%-3.00K

---16.00K

---1.00K

---23.00K

---285.00K

歸属于母公司的淨利潤

9.61%-122.93M

-250.07%-130.61M

-23.85%-106.44M

-64.98%-208.55M

-16.64%-136.00M

-141.76%-37.31M

23.37%-85.94M

-62.60%-126.41M

-119.71%-116.59M

180.80%89.35M

35.75%-112.15M

58.17%-77.74M

70.39%-53.06M

21.72%-110.58M

-37.27%-174.55M

-124.48%-185.83M

-58.37%-179.22M

-31.96%-141.25M

-37.55%-127.15M

1053.13%759.23M

-62.29%-113.16M

-450.46%-107.04M

-166.78%-92.44M

-48.34%-79.66M

-44.05%-69.73M

164.18%30.54M

372.96%138.42M

-39.91%-53.70M

-71.05%-48.41M

-33851.77%-47.59M

-105.25%-50.71M

-71.99%-38.38M

-31.78%-28.30M

-99.18%141.00K

-68.30%-24.71M

-30.06%-22.32M

-154.47%-21.48M

239.36%17.10M

-131.07%-14.68M

-370.96%-17.16M

-160.70%-8.44M

---12.27M

---6.35M

---3.64M

---3.24M

歸屬普通股東的淨利潤

9.61%-122.93M

-250.07%-130.61M

-23.85%-106.44M

-64.98%-208.55M

-16.64%-136.00M

-141.76%-37.31M

23.37%-85.94M

-62.60%-126.41M

-119.71%-116.59M

180.80%89.35M

35.75%-112.15M

58.17%-77.74M

70.39%-53.06M

21.72%-110.58M

-37.27%-174.55M

-124.48%-185.83M

-58.37%-179.22M

-31.96%-141.25M

-37.55%-127.15M

1053.13%759.23M

-62.29%-113.16M

-450.46%-107.04M

-166.78%-92.44M

-48.34%-79.66M

-44.05%-69.73M

164.18%30.54M

372.96%138.42M

-39.91%-53.70M

-71.05%-48.41M

-33851.77%-47.59M

-105.25%-50.71M

-71.99%-38.38M

-31.78%-28.30M

-99.18%141.00K

-68.30%-24.71M

-30.06%-22.32M

-154.47%-21.48M

239.36%17.10M

-131.07%-14.68M

-370.96%-17.16M

-160.70%-8.44M

---12.27M

---6.35M

---3.64M

---3.24M

基本每股收益

19.12%-1.28

-213.87%-1.37

-15.62%-1.17

-60.91%-2.40

-11.02%-1.58

-138.94%-0.44

28.60%-1.01

-51.44%-1.49

-111.34%-1.43

179.51%1.12

36.87%-1.41

59.00%-0.98

70.98%-0.67

23.48%-1.41

-34.23%-2.24

-123.94%-2.40

-54.07%-2.32

-22.77%-1.84

-26.47%-1.67

872.05%10.01

-31.65%-1.51

-382.20%-1.50

-152.20%-1.32

-28.45%-1.30

-23.32%-1.15

157.81%0.53

335.94%2.52

-23.22%-1.01

-50.64%-0.93

-26536.21%-0.92

-73.62%-1.07

-46.49%-0.82

-14.11%-0.62

-99.75%0.00

-66.87%-0.62

-29.58%-0.56

-154.62%-0.54

551.90%1.39

-131.08%-0.37

-370.97%-0.43

-160.69%-0.21

---0.31

---0.16

---0.09

---0.08

稀釋每股收益

19.12%-1.28

-213.87%-1.37

-15.62%-1.17

-60.91%-2.40

-11.02%-1.58

-138.94%-0.44

28.60%-1.01

-51.44%-1.49

-111.34%-1.43

179.51%1.12

36.87%-1.41

59.00%-0.98

70.98%-0.67

23.48%-1.41

-34.23%-2.24

-125.40%-2.40

-54.07%-2.32

-22.77%-1.84

-26.47%-1.67

827.68%9.44

-31.65%-1.51

-396.15%-1.50

-154.84%-1.32

-28.45%-1.30

-23.32%-1.15

155.09%0.51

324.59%2.40

-23.22%-1.01

-50.64%-0.93

-26536.21%-0.92

-73.62%-1.07

-46.49%-0.82

-14.11%-0.62

-99.75%0.00

-66.87%-0.62

-29.58%-0.56

-154.62%-0.54

551.90%1.39

-131.08%-0.37

-370.97%-0.43

-160.69%-0.21

---0.31

---0.16

---0.09

---0.08

每股派息

--0.00

貨幣單位

--USD

審計意見

----

常見問題

如何在 TradingKey 上查看 CRISPR Therapeutics AG 的利潤表？



先看總營收，再依序查看營業成本、毛利、營業費用、營業利益、稅前淨利、淨利和每股盈餘（EPS）。營收反映公司的業務規模，而各項獲利和利潤率則體現公司能否有效地將營收轉化為獲利。

季度利潤表和年度利潤表有什麼區別？



季度利潤表反映公司在一個為期三個月的財務季度內的經營表現，年度損益表則彙總整個財年的業績。季度數據適合用於觀察近期發展勢頭和季節性變化，年度數據則更適合評估長期成長、獲利能力和業務週期。

利潤表頁面中的同比是什麼意思？



同比（即年增率，YoY）是指將某項財務指標與上年同期進行比較，例如將本季度營收與去年同一季度的營收進行對比。與去年同期比較的數據有助於投資者觀察成長趨勢，同時減少正常季節性變化對分析的影響。

分析 CRSP 股票時，哪些利潤表指標最重要？



重要的指標包括營收成長、毛利、毛利率、營業利益、營業利益率、淨利、每股盈餘、研發費用、銷售及管理費用以及所得稅費用。投資者通常會綜合分析這些指標，以判斷公司是否正在成長、有效控制成本並提升獲利能力。

CRISPR Therapeutics AG 財年末的營收是多少？



CRISPR Therapeutics AG 2025 財年營收為 3.51M，高於上一財年的 37.31M。

CRISPR Therapeutics AG 最近一個季度的營收是多少？



CRISPR Therapeutics AG 最近一個季度的營收為 1.46M，同比增長 68.55%。

CRISPR Therapeutics AG 全年的淨利潤是多少？



CRISPR Therapeutics AG 2025 財年淨利潤為 -581.60M。

CRISPR Therapeutics AG 上一季度的淨利潤是多少？



CRISPR Therapeutics AG 最近一個季度的淨利潤為 -122.93M。

CRISPR Therapeutics AG 年度營業利潤是多少？



CRISPR Therapeutics AG 2025 財年的營業利潤為 -568.32M。

每股收益與利潤表有什麼關係？



每股收益（EPS）通常以淨利潤除以流通在外的股份數量計算，用於衡量公司平均每股創造的利潤。分析 EPS 時，還應結合股本變化、利潤率、現金流和估值指標進行綜合判斷。